Volume 14, Number 3—March 2008
Research
Epidemiology of Nontuberculous Mycobacteria in Patients without HIV Infection, New York City
Ethan E. Bodle*, Jennifer A. Cunningham*, Phyllis Della-Latta*, Neil W. Schluger*, and Lisa Saiman*
Table 2
Site of disease and species of nontuberculous mycobacteria, New York–Presbyterian Hospital, Columbia University Medical Center, New York, New York, 2000–2003*
| Site of disease | No. patients with MAC infection | No. patients with RGM infection | No. patients with other species infections | Total no. patients (%) |
|---|---|---|---|---|
| Respiratory tract | 65 | 7 | 9 | 81 (68.1) |
| Skin and soft tissue, nonsurgical | 2 | 4 | 6 | 12 (10.1) |
| Surgical sites | 0 | 7 | 2 | 9 (7.6) |
| Bloodstream | 2 | 4 | 1 | 7 (5.9) |
| Lymph node | 5 | 1 | 0 | 6 (5.0) |
| Disseminated | 2 | 0 | 0 | 2 (1.7) |
| Central nervous system | 0 | 1 | 0 | 1 (0.8) |
| Gastrointestinal tract | 0 | 0 | 1 | 1 (0.8) |
| All body sites | 76 | 24 | 19 | 119 (100) |
*MAC, Mycobacterium avium complex; RGM, rapidly growing mycobacteria.
